Gene · 7220
Papers2,976
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,976
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting TRPV6/CXCR4 complexes prevents castration-resistant prostate cancer metastasis to the bone. | Signal Transduct Target Ther | 2025 | 40908300 | PubTator, text mining | PubMed |
| Arginyltransferase1 drives a mitochondria-dependent program to induce cell death. | Cell Death Dis | 2025 | 40818972 | PubTator, text mining | PubMed |
| Extracellular bioelectrical lexicon: detecting rhythmic patterns within dermal fibroblast populations. | Sci Rep | 2025 | 40813891 | PubTator, text mining | PubMed |
| Multidimensional pan cancer analysis of the sodium induced cell death gene TRPM4. | Sci Rep | 2025 | 40804073 | PubTator, text mining | PubMed |
| Effects of chronic low-frequency pulsed magnetic fields exposure on the contractility and morphology of biceps brachii in healthy adults-a randomized controlled, double-blind trial. | Front Med (Lausanne) | 2025 | 40761872 | PubTator, text mining | PubMed |
| Eugenol: An Insight Into the Anticancer Perspective and Pharmacological Aspects. | Food Sci Nutr | 2025 | 40761498 | PubTator, text mining | PubMed |
| Biophysical and biochemical signatures of pancreatic stellate cell activation: insights into mechano-metabolic signalling from atomic force microscopy and Raman spectroscopy. | Cell Commun Signal | 2025 | 40759959 | PubTator, text mining | PubMed |
| Cell biomechanics on muscle atrophy: from intricate mechanisms to therapeutic frontiers. | Ann Med | 2025 | 40747836 | PubTator, text mining | PubMed |
| The Antioxidant and Skin-Brightening Effects of a Novel Caffeic Acid Derivative, Caffeic Acid-3,4-Dihydroxyphenylpropanolester. | Antioxidants (Basel) | 2025 | 40722910 | PubTator, text mining | PubMed |
A systems approach to pigmentation control by ascorbic acid esterified with coconut oil-derived medium-chain fatty acids: Investigated via network pharmacology, molecular dynamics, elastic network and Markov state models. | Comput Biol Chem | 2025 | 40695099 | PubTator, text mining | PubMed |
| Enhanced neuromorphogenesis of neural stem cells via the optimization of physical stimulus-responsive signaling pathways. | Stem Cell Res Ther | 2025 | 40682198 | PubTator, text mining | PubMed |
| Acoustic technologies for the orchestration of cellular functions for therapeutic applications. | Sci Adv | 2025 | 40680134 | PubTator, text mining | PubMed |
| Molecular evolution of TRPC4 regulatory sequences supports a role in mammalian thermoregulatory adaptation. | PeerJ | 2025 | 40656937 | PubTator, text mining | PubMed |
| TRPC1 and TRPC5 in Colorectal Cancer: Mechanisms, Prognostic Markers, and Therapeutic Targets. | Drug Dev Res | 2025 | 40635385 | PubTator, text mining | PubMed |
| TRPC1-5-5-5 heteromer as a sodium sensor. | Biochem Biophys Res Commun | 2025 | 40616983 | PubTator, text mining | PubMed |
| Transient Receptor Potential Channels in Physiology and Pathophysiology: Special Issue. | Int J Mol Sci | 2025 | 40430100 | PubTator, text mining | PubMed |
| Identification of biomarkers of male infertility through the circRNA expression profiling of seminal plasma. | J Biomed Res | 2025 | 40391511 | PubTator, text mining | PubMed |
| Apigenin promotes melanogenesis and melanosome transport through the c-KIT/Raf-1/MAPK/CREB pathway in HEMCs. | Front Pharmacol | 2025 | 40356959 | PubTator, text mining | PubMed |
| Transient Receptor Potential Channels in Prostate Cancer: Associations with ERG Fusions and Survival. | Int J Mol Sci | 2025 | 40332161 | PubTator, text mining | PubMed |
| Piezo1-induced durotaxis of pancreatic stellate cells depends on TRPC1 and TRPV4 channels. | J Cell Sci | 2025 | 40019468 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7220/papers?page=3